Telesis Bio Inc. financial data

Symbol
TBIO on OTC
Industry
Laboratory Analytical Instruments
Location
10431 Wateridge Circle, Suite 150, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
Codex DNA, Inc. (to 10/28/2022)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 263 % -24.9%
Quick Ratio 33.6 % +61.3%
Debt-to-equity -262 % -265%
Return On Equity 327 %
Return On Assets -86.3 % -120%
Operating Margin -266 % -100%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.78M shares -94.1%
Common Stock, Shares, Outstanding 1.77M shares -94.1%
Entity Public Float 14.2M USD -15.5%
Common Stock, Value, Issued 0 USD -100%
Weighted Average Number of Shares Outstanding, Basic 1.77M shares +6.55%
Weighted Average Number of Shares Outstanding, Diluted 1.77M shares +6.55%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.6M USD -38.1%
Cost of Revenue 9.05M USD -3.99%
Research and Development Expense 12.7M USD -25.8%
Selling and Marketing Expense 8.06M USD -41.5%
General and Administrative Expense 18.3M USD -17.6%
Operating Income (Loss) -44.2M USD -24%
Nonoperating Income (Expense) -1.07M USD +11.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -45.3M USD -22.8%
Income Tax Expense (Benefit) 7K USD -74.1%
Net Income (Loss) Attributable to Parent -45.6M USD -19.3%
Earnings Per Share, Basic -0.29 USD/shares +98.5%
Earnings Per Share, Diluted -0.29 USD/shares +98.5%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.72M USD -78.6%
Accounts Receivable, after Allowance for Credit Loss, Current 1.26M USD -76.4%
Inventory, Net 1.1M USD -74.3%
Assets, Current 8.12M USD -84.6%
Operating Lease, Right-of-Use Asset 7.9M USD -71.5%
Intangible Assets, Net (Excluding Goodwill) 638K USD -57.4%
Goodwill 3.5M USD -76.5%
Assets 24.7M USD -76.4%
Accounts Payable, Current 1.49M USD -37.8%
Employee-related Liabilities, Current 1.93M USD -46.8%
Contract with Customer, Liability, Current 263K USD -77.7%
Liabilities, Current 6.63M USD -73.9%
Contract with Customer, Liability, Noncurrent 149K USD +26.3%
Operating Lease, Liability, Noncurrent 7.86M USD -71.5%
Liabilities 20.9M USD -64.4%
Accumulated Other Comprehensive Income (Loss), Net of Tax -5K USD +66.7%
Retained Earnings (Accumulated Deficit) -189M USD -31.7%
Stockholders' Equity Attributable to Parent -27.2M USD -253%
Liabilities and Equity 24.7M USD -76.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -3.24M USD +71%
Net Cash Provided by (Used in) Financing Activities -27K USD -50%
Net Cash Provided by (Used in) Investing Activities 12.2M USD +197%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 1.77M shares -94.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 8.98M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.82M USD -78.3%
Interest Paid, Excluding Capitalized Interest, Operating Activities 162K USD -68.2%
Deferred Tax Assets, Valuation Allowance 41.8M USD +42.1%
Deferred Tax Assets, Gross 49.1M USD +61%
Operating Lease, Liability 9.88M USD -66.2%
Depreciation 2.02M USD +32.4%
Payments to Acquire Property, Plant, and Equipment 502K USD +6.81%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -45.5M USD -19.3%
Lessee, Operating Lease, Liability, to be Paid 14.5M USD -68%
Operating Lease, Liability, Current 2.02M USD +23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.36M USD -70.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.33M USD -69.9%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure +10.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 4.66M USD -71.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD -69%
Deferred Tax Assets, Operating Loss Carryforwards 28.7M USD +15.4%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares
Unrecognized Tax Benefits 338K USD -23.7%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.45M USD -68.9%
Operating Lease, Payments 548K USD +18.9%
Additional Paid in Capital 162M USD +0.34%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 515K USD -2.83%
Deferred Tax Assets, Net of Valuation Allowance 7.31M USD +580%
Share-based Payment Arrangement, Expense 2.82M USD -39.3%
Interest Expense 214K USD -69.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares